3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
14
Sarcoma
11
Glioblastoma
11
Squamous Cell Carcinoma of Head and Neck
10
Rectal Neoplasms
8
Esophageal Neoplasms
8
Stomach Neoplasms
7
Urinary Bladder Neoplasms
6
Neoplasms
6
Carcinoma, Hepatocellular
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Hypopharyngeal Neoplasms
4
Head and Neck Neoplasms
4
Glioma
4
Colonic Neoplasms
4
Recurrence
3
Prostatic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Astrocytoma
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Interventions
tremelimumab
4
Ipilimumab
4
lenvatinib
3
durvalumab
3
Nivolumab
3
pembrolizumab
2
balstilimab
2
Pemetrexed
2
Carboplatin
2
Bevacizumab
2
spartalizumab
1
relatlimab
1
poly ICLC
1
osimertinib
1
cemiplimab
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Standard of Care
1
Platinum
1
Peptides
1
Paclitaxel
1
Opdualag
1
Docetaxel
1
Capecitabine
1
Blood Specimen Collection
1
Axitinib
1
Antibodies, Bispecific
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Surgical Procedures, Operative
×
1 year
×
Clear all
No trials found.